Search

everythinglearnresearchcommunity

for

Search:↓

More research is needed to understand how testosterone is maintained in adult males.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Resveratrol improved hormone levels, menstrual cycles, hair loss, and ovarian function in PCOS patients.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Most cases of high male hormone levels in women are due to polycystic ovary syndrome.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Pre-operative hormone treatment for hypospadias surgery might improve outcomes, but more research is needed to confirm.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.